Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Illumina Acquires Advanced Liquid Logic

Published: Wednesday, July 24, 2013
Last Updated: Wednesday, July 24, 2013
Bookmark and Share
Acquisition a key component in the development of complete sample-to-answer solutions for next-generation sequencing.

Illumina, Inc. announced that it has acquired Advanced Liquid Logic (ALL), a leading provider of liquid handling solutions. ALL, now a wholly owned subsidiary of Illumina, has developed a proprietary “digital microfluidics” technology based on electrowetting that precisely manipulates small droplets within a sealed disposable cartridge to perform complex laboratory protocols. This proven technology will enable Illumina to deliver the simplest and most efficient sample-to-answer next-generation sequencing (NGS) workflow.

“For our research customers, ALL’s technology will further streamline the industry's simplest NGS workflow, while for clinical and applied markets, where ease of use and consistency are especially valued, it will allow us to offer integrated, end-to-end solutions,” said Christian Henry, Senior Vice President and General Manager of Illumina’s Genomic Solutions business. “ALL brings an impressive IP portfolio in digital microfluidics and a talented team with a track record of innovation.”

One of Illumina's goals is to provide customers with a holistic set of tools to go from biological sample to answer quickly and easily, minimizing the risk of errors and reducing hands-on time in the lab. To that end, Illumina recently announced it is collaborating with leading vendors of liquid handling robotic platforms to make automation solutions for high-throughput sample preparation more accessible. With its acquisition of ALL, Illumina will be able to introduce similar benefits to its low- and mid-throughput customers.

ALL’s versatile technology has been demonstrated across numerous applications, including nucleic acid isolation from various sample types and library generation for next-generation sequencing. Its robust solution has a clear advantage in precisely handling low sample volumes, which is an increasingly important focus for customers.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Illumina Receives FDA 510(k) Clearance for its BeadXpress® Multiplex Analysis System
BeadXpress system is designed for simultaneous detection of multiple analytes in a DNA sample utilizing VeraCode holographic microbead technology.
Tuesday, May 04, 2010
Illumina Announces Scale-Up of Genome Analyzers at the Broad Institute
Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.
Friday, November 06, 2009
Illumina Announces Roadmap to Five Million Variants for Next-Generation Whole-Genome Genotyping
Illumina has outlined an ongoing collaboration with leading researchers to select the highest-value markers from the 1000 Genomes Project for GWAS.
Friday, October 23, 2009
Illumina Announces LIFE & BRAIN as Germany's First Certified Genetic Analysis Service Provider
Illumina CSPro is a collaborative service provider partnership dedicated to ensuring the delivery of quality data available for genetic analysis applications.
Monday, June 23, 2008
Illumina Announces Mitsubishi Chemical Safety Institute as Japan's First Certified Genetic Analysis Service Provider
The Institute offers its customers whole-genome and targeted-genotyping services using Illumina's Infinium® and GoldenGate® Assays.
Friday, June 20, 2008
Illumina Introduces Three new Research Products to Study Genetic Variations Linked to Cancer Development
The expansion will enable profiling of cancer’s unique gene expression and methylation signatures.
Saturday, April 12, 2008
Illumina Sequences the First African Human Genome
Accomplishment marks a significant milestone enabling economical human genome resequencing.
Thursday, February 07, 2008
Mexico's National Institute of Genomic Medicine Unveils new Illumina Genotyping and Gene Expression Analysis Facility
The new unit is part of a 40,000 square foot facility being constructed by INMEGEN and will house a fully-automated Illumina BeadStation.
Tuesday, July 10, 2007
Illumina Commences Shipment of the Human1M BeadChip
Illumina began shipment of the Human1M DNA analysis beadchip that contains more than one million single-nucleotide polymorphisms on a single chip.
Monday, July 02, 2007
Illumina Announces Publication of the Peer-Reviewed ChIP-Seq Studies Using Solexa® Technology
Studies published in Science and Cell demonstrates a transformation in the way scientists look at the DNA-protein interactions that alter gene function and regulation.
Friday, June 08, 2007
Illumina Announces Collaboration with top Five Pharmaceutical Companies
Company announces collaboration for the purchase and installation of a multi-component genetic analysis system.
Wednesday, October 18, 2006
Federal Microarray Quality Control Study Addresses Intercompatibility of Microarray Gene Expression Platforms
Results pave the way for researchers to choose platform based on performance, value and quality of content.
Monday, September 11, 2006
Illumina to Develop iSelect Bovine BeadChip with Three Collaborating Institutions
Genome-wide SNP content designed to improve selection for multiple breeds of cattle.
Friday, August 25, 2006
Shafallah Center Purchases Illumina® Beadlab
Illumina technology platform enables large-scale disease association studies.
Wednesday, May 10, 2006
Illumina Awarded Genotyping Contract by SAIC-Frederick
Illumina will perform whole-genome SNP scans on over 2,500 prostrate case and control samples.
Wednesday, February 15, 2006
Scientific News
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Artificial Pancreas Controls Diabetes
Scientists are reporting the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Major Step for Implantable Drug-Delivery Device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Smart Insulin Patch Could Replace Painful Injections for Diabetes
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
New Tool on Horizon for Surgeons Treating Cancer Patients
Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers.
Heartbeat on a Chip Could Improve Pharmaceutical Tests
A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!